We4 Insights
Healthcare is evolving, and so is innovation.
Join our community to explore the latest insights on digital health, clinical research, telemedicine, and regulatory transformation.
Get updates, expert perspectives, and thought
leadership delivered straight to your inbox.
Stay informed. Stay ahead.
Healthcare evolves fast and innovation doesn’t wait.
Subscribe to receive updates on digital health, clinical research, telemedicine,
and regulatory strategy.
Expert insights, real-world perspectives, and key events from the We4 ecosystem delivered directly to your inbox.
Because better decisions start with better knowledge.
Risk-based means protecting what matters most
In clinical research, risk-based approaches are everywhere: they appear in protocols, monitoring plans, and quality systems. But there is a growing misunderstanding. Many organizations treat risk-based as a justification to reduce activities: fewer checks, lighter processes, less on-site monitoring. The goal is often simple: cut time and cost. Technically and regulatorily, this interpretation is wrong.…
Digital twins in Clinical trials: a new way of designing studies
In the past year, Digital twin has become one of the most overused terms in healthcare innovation. It appears in conference slides, CRO strategy decks, and investor presentations, often described as a virtual copy of a patient, ready to be tested like an avatar in a simulation. But the reality is less cinematic and far…
MDR – Racing Against Time for Your CE Mark
The extension is here, but it’s not a safety net. Learn how to move fast, stay compliant, and protect your market share. With Regulation (EU) 2023/607, the European Commission has introduced a critical extension to MDR deadlines for legacy devices certified under the previous MDD (Directive 93/42/EEC). It’s a valuable opportunity—but not an excuse to delay.…
GCP R3 – Episode 1: What you need to know (Especially if you work in MedTech)
GCP R3: GCP is evolving, are you? The ICH has released the E6(R3) revision of Good Clinical Practice (GCP), and it marks a turning point. With this update, the rules of clinical evidence have changed, and if you’re working on medical devices, SaMD or digital health, you’re in the game now too. No need to worry, here’s a…
MDR 2025: What’s Really Changing and How to Prepare Now
The MDR deadline extension is not a pause. It’s a strategic opportunity – but only if you act early. Back in early 2024, the European Commission granted more time for companies to align with Regulation (EU) 2017/745 (MDR) – particularly concerning legacy devices. While many manufacturers welcomed the extra breathing room, be careful: more time doesn’t mean fewer…
We4 Clinical Research Prepares for the Gender Equality Certification: Our Commitment to an Equitable and Inclusive Work Environment
In recent years, the issue of gender equality has taken on central importance. Companies are actively working to ensure equal opportunities, pay equity, and inclusive environments where every employee can fully realize their potential. At We4 Clinical Research, we firmly believe that valuing diversity is essential for driving innovation, productivity, and sustainable growth. Towards the…